Biotech · Private company · Katy, TX, US

Constantiam Biosciences Inc.

Track this companyFree. Adds Constantiam Biosciences Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Leveraging high-throughput functional data for assessment of Alzheimer's riskFiscal year 2026 · $1.3MNIH RePORTER 2R44AG084431-02 · fetched Nov 12, 2026
Platform to support clinical variant interpretation through probabilistic assessment of functional evidenceFiscal year 2025 · $1MNIH RePORTER 5R44HG012535-03 · fetched Nov 12, 2026
Leveraging high-throughput functional data for assessment of Alzheimer's riskFiscal year 2024 · $485.2KNIH RePORTER 1R43AG084431-01A1 · fetched Nov 12, 2026
Platform to support clinical variant interpretation through probabilistic assessment of functional evidenceFiscal year 2024 · $1MNIH RePORTER 2R44HG012535-02 · fetched Nov 12, 2026